Halozyme Therapeutics
Industry: Biotechnology company
DescriptionHalozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. CEO: Helen I. Torley (Jan 6, 2014–) Headquarters: San Diego, CA CFO: Laurie D. Stelzer Number of employees: 260
Halozyme Therapeutics List of Employees There's an exhaustive list of past and present employees! Get comprehensive information on the number of employees at Halozyme Therapeutics. You can filter them based on skills, years of employment, job, education, department, and prior employment.
Halozyme Therapeutics Salaries. You can even request information on how much does Halozyme Therapeutics pay if you want to. Learn about salaries, pros and cons of working for Halozyme Therapeutics directly from the past employees.
Find People by Employers You can rekindle an old relationship, reconnect with a long-lost friend, former boss, business acquaintance who might be useful in your new line of work. With our employee database, the possibilities are endless. All you have to do is type in a couple of keywords and we'll bring you the exact information you wanted!
12 Halozyme Therapeutics employees in database. Find out everything there's to know about Halozyme Therapeutics employees. We offer you a great deal of unbiased information from the internal database, personal records, and many other details that might be of interest to you.
Halozyme Therapeutics Employees
Employee
Years
Job
Industry
Mysore Ramprasad, Ph.D. Mysore Ramprasad, Ph.D.'s Halozyme Therapeutics Experience 2008 - 2011
Job Principal Scientist and Project Leader, aTyr Pharma
Industry Pharmaceuticals
Experience
aTyr Pharma January 2013 - Present
CMC Biologics Icos 2011 - 2013
Halozyme Therapeutics 2008 - 2011
CovX (Pfizer Biologics, San Diego) 2004 - 2008
Favrille 2003 - 2004
SkyePharma 1998 - 2003
Skills
Biotechnology, Biopharmaceuticals, Protein Chemistry, HPLC, GLP, In Vitro, Drug Delivery, Assay Development, Monoclonal Antibodies, Formulation, Antibodies, GMP, Biochemistry, Technology Transfer, Purification, Life Sciences
Education
University of California, San Diego
Asst. Research Professor, Department of Medicine
aTyr Pharma January 2013 - Present
CMC Biologics Icos 2011 - 2013
Halozyme Therapeutics 2008 - 2011
CovX (Pfizer Biologics, San Diego) 2004 - 2008
Favrille 2003 - 2004
SkyePharma 1998 - 2003
Skills
Biotechnology, Biopharmaceuticals, Protein Chemistry, HPLC, GLP, In Vitro, Drug Delivery, Assay Development, Monoclonal Antibodies, Formulation, Antibodies, GMP, Biochemistry, Technology Transfer, Purification, Life Sciences
Education
University of California, San Diego
Asst. Research Professor, Department of Medicine
Jey Won Jey Won's Halozyme Therapeutics Experience 2009 - 2009
Job Business & Corporate Development @ Human Longevity, Inc (HLI)
Industry Biotechnology
Experience
Human Longevity, Inc. (HLI) 2015 - Present
Vault Bioventures 2011 - 2014
Novartis Pharmaceuticals 2009 - 2010
Halozyme Therapeutics 2009 - 2009
McKinsey & Company 2002 - 2008
Education
Massachusetts Institute of Technology 2000 — 2002
Master of Science
Stanford University 2000 — 2000
Visiting Graduate Student
Rutgers University-New Brunswick 1996 — 2000
Bachelor of Science
Human Longevity, Inc. (HLI) 2015 - Present
Vault Bioventures 2011 - 2014
Novartis Pharmaceuticals 2009 - 2010
Halozyme Therapeutics 2009 - 2009
McKinsey & Company 2002 - 2008
Education
Massachusetts Institute of Technology 2000 — 2002
Master of Science
Stanford University 2000 — 2000
Visiting Graduate Student
Rutgers University-New Brunswick 1996 — 2000
Bachelor of Science
Mark Roman, PhD. Mark Roman, PhD.'s Halozyme Therapeutics Experience 2007 - 2010
Job Available
Industry Pharmaceuticals
Experience
GNF September 2012 - Present
UCSD Biofuel Technology Program April 2012 - September 2012
Mark Roman Consulting July 2011 - August 2012
Halozyme Therapeutics 2007 - 2010
UCSD School of Medicine 2004 - 2007
Halozyme Therapeutics 2003 - 2004
University of California San Diego, School of Medicine 1998 - 2001
Dynavax Technologies 1996 - 1998
Skills
Assay Development, ELISA, Mutagenesis, DNA, qPCR, biofuels studies, marine microbiology, commercial cell line..., viral vectors, gene expression, bio-informatics, plasmid production, large scale transfection, Th1-immune system bias, DNA vaccines, human xenograft, muscle stem cell..., Viral Vectors, Culture, Molecular Biology, Western Blotting, Biochemistry, Bioinformatics, Cell Culture, Cell, In Vivo, In Vitro, Vaccines, Biotechnology, Isolation, Protein Purification, Gene Expression, Biopharmaceuticals, Cell Biology, Stem Cells, Protein Chemistry, Drug Discovery, Molecular Cloning, RT-PCR, Tissue Culture, Animal Models
Education
University of California, San Diego 1987 — 1994
PhD, biomedical sciences
UCSD School of Medicine
Physiology / Pharmacology, Molecular biology / Virology
GNF September 2012 - Present
UCSD Biofuel Technology Program April 2012 - September 2012
Mark Roman Consulting July 2011 - August 2012
Halozyme Therapeutics 2007 - 2010
UCSD School of Medicine 2004 - 2007
Halozyme Therapeutics 2003 - 2004
University of California San Diego, School of Medicine 1998 - 2001
Dynavax Technologies 1996 - 1998
Skills
Assay Development, ELISA, Mutagenesis, DNA, qPCR, biofuels studies, marine microbiology, commercial cell line..., viral vectors, gene expression, bio-informatics, plasmid production, large scale transfection, Th1-immune system bias, DNA vaccines, human xenograft, muscle stem cell..., Viral Vectors, Culture, Molecular Biology, Western Blotting, Biochemistry, Bioinformatics, Cell Culture, Cell, In Vivo, In Vitro, Vaccines, Biotechnology, Isolation, Protein Purification, Gene Expression, Biopharmaceuticals, Cell Biology, Stem Cells, Protein Chemistry, Drug Discovery, Molecular Cloning, RT-PCR, Tissue Culture, Animal Models
Education
University of California, San Diego 1987 — 1994
PhD, biomedical sciences
UCSD School of Medicine
Physiology / Pharmacology, Molecular biology / Virology
Steve Linton, PhD PMP Steve Linton, PhD PMP's Halozyme Therapeutics Experience 2007 - 2014
Job Director, Program Management at Intercept Pharmaceuticals
Industry Pharmaceuticals
Experience
Halozyme Therapeutics 2007 - 2014
Novasite 2006 - 2006
Idun Pharmaceuticals 1995 - 2005
Gensia, Inc. 1992 - 1995
Education
Rice University
PhD, Chemistry
Texas Christian University
BS, Chemistry
Halozyme Therapeutics 2007 - 2014
Novasite 2006 - 2006
Idun Pharmaceuticals 1995 - 2005
Gensia, Inc. 1992 - 1995
Education
Rice University
PhD, Chemistry
Texas Christian University
BS, Chemistry
Jason Liles Jason Liles's Halozyme Therapeutics Experience February 2006 - November 2007
Job Senior Product Manager, US Surgical
Industry Marketing and Advertising
Experience
Molnlycke Health Care US December 2011 - Present
Brain Surgery Worldwide, LLC February 2011 - December 2011
PharmaMed Research, Inc. May 2009 - September 2009
Halozyme Therapeutics, Inc. December 2007 - July 2008
Halozyme Therapeutics February 2006 - November 2007
Skills
Biotechnology, Business Development, Product Management, Contract Negotiation, Trade Shows, Medical Devices, Marketing Strategy, Market Research, Strategic Planning, Sales, Management, Start-ups, Pharmaceutical Industry, New Business Development, Marketing, Strategy, Direct Sales, Mergers & Acquisitions, Product Launch, Market Analysis, Product Development, Lifesciences, Competitive Analysis, Sales Operations, Sales Effectiveness, Product Marketing, Cross-functional Team..., Market Development, Healthcare, Pharmaceutical Sales, Market Planning, Selling, Global Marketing, Commercialization, Operating Room
Education
Vanderbilt University - Owen Graduate School of Management 2008 — 2010
Master of Business Administration, Strategy, Marketing, Entrepreneurship
Clemson University 1999 — 2005
Bachelor of Science, Biochemistry
Molnlycke Health Care US December 2011 - Present
Brain Surgery Worldwide, LLC February 2011 - December 2011
PharmaMed Research, Inc. May 2009 - September 2009
Halozyme Therapeutics, Inc. December 2007 - July 2008
Halozyme Therapeutics February 2006 - November 2007
Skills
Biotechnology, Business Development, Product Management, Contract Negotiation, Trade Shows, Medical Devices, Marketing Strategy, Market Research, Strategic Planning, Sales, Management, Start-ups, Pharmaceutical Industry, New Business Development, Marketing, Strategy, Direct Sales, Mergers & Acquisitions, Product Launch, Market Analysis, Product Development, Lifesciences, Competitive Analysis, Sales Operations, Sales Effectiveness, Product Marketing, Cross-functional Team..., Market Development, Healthcare, Pharmaceutical Sales, Market Planning, Selling, Global Marketing, Commercialization, Operating Room
Education
Vanderbilt University - Owen Graduate School of Management 2008 — 2010
Master of Business Administration, Strategy, Marketing, Entrepreneurship
Clemson University 1999 — 2005
Bachelor of Science, Biochemistry
Allen Albright, PhD Allen Albright, PhD's Halozyme Therapeutics Experience October 2012 - September 2014
Job Head of Regulatory Affairs & Quality Assurance at Mirati Therapeutics
Industry Pharmaceuticals
Experience
Mirati Therapeutics September 2014 - Present
Halozyme Therapeutics October 2012 - September 2014
Consultant March 2012 - September 2012
Anadys Pharmaceuticals (acquired by Roche) May 2007 - February 2012
Agensys (acquired by Astellas Pharma) 2004 - 2007
Baxter BioScience 2003 - 2004
Amgen 2000 - 2003
FDA 1996 - 2000
Skills
Regulatory Affairs, Regulatory Strategy, FDA, Regulatory Submissions, Project Management, Quality Assurance, Drug Development, Fast Track, Orphan Drugs, Due Diligence, Regulatory Intelligence, Cross-functional Team..., Regulatory Affairs..., Consulting, Clinical Development, Biotechnology, Clinical Trials, Strategy, Pharmaceutical Industry, GMP, GLP, Infectious Diseases, Medical Devices, Vaccines, Clinical Research, Molecular Biology, IND, Cancer, Monoclonal Antibodies, Protein Chemistry, CMC, Pharmaceutics
Education
The Johns Hopkins University School of Medicine 1994 — 1996
Postdoctoral Fellow
Uniformed Services University of the Health Sciences - F Edward Hebert SOM 1988 — 1994
PhD, Microbiology & Immunology
Virginia Polytechnic Institute and State University 1980 — 1984
BS, Biology
Mirati Therapeutics September 2014 - Present
Halozyme Therapeutics October 2012 - September 2014
Consultant March 2012 - September 2012
Anadys Pharmaceuticals (acquired by Roche) May 2007 - February 2012
Agensys (acquired by Astellas Pharma) 2004 - 2007
Baxter BioScience 2003 - 2004
Amgen 2000 - 2003
FDA 1996 - 2000
Skills
Regulatory Affairs, Regulatory Strategy, FDA, Regulatory Submissions, Project Management, Quality Assurance, Drug Development, Fast Track, Orphan Drugs, Due Diligence, Regulatory Intelligence, Cross-functional Team..., Regulatory Affairs..., Consulting, Clinical Development, Biotechnology, Clinical Trials, Strategy, Pharmaceutical Industry, GMP, GLP, Infectious Diseases, Medical Devices, Vaccines, Clinical Research, Molecular Biology, IND, Cancer, Monoclonal Antibodies, Protein Chemistry, CMC, Pharmaceutics
Education
The Johns Hopkins University School of Medicine 1994 — 1996
Postdoctoral Fellow
Uniformed Services University of the Health Sciences - F Edward Hebert SOM 1988 — 1994
PhD, Microbiology & Immunology
Virginia Polytechnic Institute and State University 1980 — 1984
BS, Biology
Curtis Thompson Curtis Thompson's Halozyme Therapeutics Experience March 2007 - August 2007
Job Senior Director of Pharmacology & Tumor Biology at Halozyme Therapeutics, Inc.
Industry Pharmaceuticals
Experience
Halozyme Therapeutics, Inc. January 2013 - Present
Halozyme Therapeutics, Inc. January 2010 - December 2012
Halozyme Therapeutics, Inc. January 2009 - December 2009
Halozyme Therapeutics, Inc. September 2007 - December 2008
Halozyme Therapeutics March 2007 - August 2007
Isis Pharmaceuticals February 2005 - November 2005
Isis Pharmaceuticals August 2002 - January 2005
Isis Pharmaceuticals January 2002 - August 2002
University of California, San Diego January 2000 - November 2001
Skills
Drug Discovery, In Vivo, Pharmacology, Biotechnology, Lifesciences, Drug Development, Assay Development, Clinical Development, IND, Animal Models, Biochemistry, Molecular Biology, Biomarkers, Translational Research, Cell Culture, ELISA, Oncology, Pharmaceutical Industry, Translational Medicine, CRO, Biomarker Discovery, Inflammation, Cell, Cancer, Regulatory Submissions, Pharmacokinetics, Biopharmaceuticals, R&D, Cell Biology, Protocol, Technology Transfer, Science, Life Sciences, In Vitro, Immunology, DNA, Western Blotting, Physiology, Biologics, Laboratory, Pharmacodynamics, qPCR, Genetics, Biology, Regulatory Requirements, FDA, GLP, PCR, GMP
Education
Johns Hopkins University Advanced Academic Programs 2015 — 2018
Master of Biotechnology Enterprises and Entrepreneurship (MBEE)
Keck School of Medicine of the University of Southern California 1993 — 1998
Ph.D.
University of California, Davis 1981 — 1986
B.Sc.
Halozyme Therapeutics, Inc. January 2013 - Present
Halozyme Therapeutics, Inc. January 2010 - December 2012
Halozyme Therapeutics, Inc. January 2009 - December 2009
Halozyme Therapeutics, Inc. September 2007 - December 2008
Halozyme Therapeutics March 2007 - August 2007
Isis Pharmaceuticals February 2005 - November 2005
Isis Pharmaceuticals August 2002 - January 2005
Isis Pharmaceuticals January 2002 - August 2002
University of California, San Diego January 2000 - November 2001
Skills
Drug Discovery, In Vivo, Pharmacology, Biotechnology, Lifesciences, Drug Development, Assay Development, Clinical Development, IND, Animal Models, Biochemistry, Molecular Biology, Biomarkers, Translational Research, Cell Culture, ELISA, Oncology, Pharmaceutical Industry, Translational Medicine, CRO, Biomarker Discovery, Inflammation, Cell, Cancer, Regulatory Submissions, Pharmacokinetics, Biopharmaceuticals, R&D, Cell Biology, Protocol, Technology Transfer, Science, Life Sciences, In Vitro, Immunology, DNA, Western Blotting, Physiology, Biologics, Laboratory, Pharmacodynamics, qPCR, Genetics, Biology, Regulatory Requirements, FDA, GLP, PCR, GMP
Education
Johns Hopkins University Advanced Academic Programs 2015 — 2018
Master of Biotechnology Enterprises and Entrepreneurship (MBEE)
Keck School of Medicine of the University of Southern California 1993 — 1998
Ph.D.
University of California, Davis 1981 — 1986
B.Sc.
Donna Callaway Donna Callaway's Halozyme Therapeutics Experience March 2007 - Present
Job Executive Assistant at Halozyme Therapeutics
Industry Biotechnology
Experience
Halozyme Therapeutics March 2007 - Present
Elan Pharmaceuticals September 2001 - July 2006
Elan 2001 - 2006
The Weiss Group, LLC 1998 - 2001
Skills
FDA, Biotechnology, Pharmaceutical Industry, Clinical Development, Oncology, Regulatory Submissions, Clinical Trials, Lifesciences, CTMS, Executive Administrative, Regulatory Affairs, Life Sciences, GMP, Medical Devices
Education
Palomar College 1982 — 1983
Court Reporting Institute
Shorthand Theory, Director of Education
Halozyme Therapeutics March 2007 - Present
Elan Pharmaceuticals September 2001 - July 2006
Elan 2001 - 2006
The Weiss Group, LLC 1998 - 2001
Skills
FDA, Biotechnology, Pharmaceutical Industry, Clinical Development, Oncology, Regulatory Submissions, Clinical Trials, Lifesciences, CTMS, Executive Administrative, Regulatory Affairs, Life Sciences, GMP, Medical Devices
Education
Palomar College 1982 — 1983
Court Reporting Institute
Shorthand Theory, Director of Education
Norm Herman's Halozyme Therapeutics Experience February 2005 - February 2007
Job Director of Manufacturing and Biopharmaceutical Technology at Halozyme Therapeutics, Inc.
Industry Biotechnology
Experience
Halozyme Therapeutics, Inc. March 2007 - Present
Halozyme Therapeutics February 2005 - February 2007
Purdue Pharma L.P. 1991 - 2001
Education
Columbia University in the City of New York 1967 — 1972
BS, Pharmacy
Halozyme Therapeutics, Inc. March 2007 - Present
Halozyme Therapeutics February 2005 - February 2007
Purdue Pharma L.P. 1991 - 2001
Education
Columbia University in the City of New York 1967 — 1972
BS, Pharmacy
Francois Nicol, Ph.D.'s Halozyme Therapeutics Experience March 2012 - Present
Job Director, Pharmaceutical Development at Halozyme Therapeutics
Industry Pharmaceuticals
Experience
Halozyme Therapeutics March 2012 - Present
Halozyme Therapeutics June 2008 - March 2012
ALZA Corporation February 2002 - February 2008
Transgene SA August 2000 - December 2001
Valentis, Inc February 1999 - July 2000
University of California, San Francisco 1994 - 1998
Skills
Protein Chemistry, HPLC, Drug Delivery, Assay Development, Clinical Development, Formulation, UV/Vis, In Vitro, GMP, Purification, Oncology, In Vivo, CRO, Cancer, Life Sciences, Pharmaceutical Industry, Validation
Education
Université Bordeaux I 1994 — 1998
PhD, Physical Chemistry
Ecole nationale supérieure de Chimie et de Physique de Bordeaux 1991 — 1994
Engineering, Physics and Chemistry
Halozyme Therapeutics March 2012 - Present
Halozyme Therapeutics June 2008 - March 2012
ALZA Corporation February 2002 - February 2008
Transgene SA August 2000 - December 2001
Valentis, Inc February 1999 - July 2000
University of California, San Francisco 1994 - 1998
Skills
Protein Chemistry, HPLC, Drug Delivery, Assay Development, Clinical Development, Formulation, UV/Vis, In Vitro, GMP, Purification, Oncology, In Vivo, CRO, Cancer, Life Sciences, Pharmaceutical Industry, Validation
Education
Université Bordeaux I 1994 — 1998
PhD, Physical Chemistry
Ecole nationale supérieure de Chimie et de Physique de Bordeaux 1991 — 1994
Engineering, Physics and Chemistry
Amgen
Biogen Idec
Gilead Sciences
Celgene
Biogen
Amgen Inc
bioMerieux
Centocor